Загрузка...
A Review of the Clinical Pharmacokinetics, Pharmacodynamics, and Immunogenicity of Vedolizumab
Vedolizumab is a humanized anti-α(4)β(7) integrin monoclonal antibody that selectively blocks trafficking of memory T cells to inflamed gut tissue by inhibiting the α(4)β(7)-mucosal addressin cell adhesion molecule-1 (MAdCAM-1) interaction. Approved for treating patients with moderately to severely...
Сохранить в:
| Опубликовано в: : | Clin Pharmacokinet |
|---|---|
| Главные авторы: | , , , , , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Springer International Publishing
2017
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5648740/ https://ncbi.nlm.nih.gov/pubmed/28523450 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s40262-017-0546-0 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|